---

Vivek Ramaswamy

Founder and Chief Executive Officer, Roivant Sciences

Vivek founded Roivant, a company that in-licenses late-stage drug candidates and develops them through subsidiaries, in 2014. Axovant, Myovant, Enzyvant, and Dermavant are some of the company’s subsidiaries, developing drugs for Alzheimers disease, women’s health, rare diseases and skin diseases, respectively.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018